Show simple item record

dc.contributor.authorVaras Doval, Raquel
dc.contributor.authorGastelurrutia, Miguel Ángel
dc.contributor.authorBenrimoj, Shalom I
dc.contributor.authorZarzuelo Romero, María José 
dc.contributor.authorPérez Escamilla, Beatriz
dc.contributor.authorMartínez Martínez, Fernando 
dc.date.accessioned2020-12-14T12:17:13Z
dc.date.available2020-12-14T12:17:13Z
dc.date.issued2020-08-14
dc.identifier.citationVaras-Doval R, Gastelurrutia MA, Benrimoj SI, et al. Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice. BMJ Open 2020;10:e036669. [doi:10.1136/ bmjopen-2019-036669]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/64888
dc.description.abstractObjectives To evaluate an implementation programme of a community pharmacy medication review with follow-up (MRF) service using a hybrid effectiveness-implementation study design, and to compare the clinical and humanistic outcomes with those in a previously conducted cluster randomised controlled trial (cRCT). Setting Community pharmacies in Spain. Participants 135 community pharmacies and 222 pharmacists providing MRF to polymedicated patients aged 65 or over. Intervention The intervention was an implementation programme for the MRF service. A national level group was established, mirrored with a provincial level group. A series of interventions were defined (1) to engage pharmacy owners with the implementation model and (2) to provide training to pharmacists consisting of clinical case studies, process of MRF, communication skills and data collection methods and (3) practice change facilitators. Primary and secondary outcome measures The primary outcomes for the implementation programme were progress, reach, fidelity and integration. The secondary outcomes were number of medications, non-controlled health problems, emergency visits, hospitalisations and health-related quality of life, which were compared with a previous 6-month cluster RCT. Results 55% of pharmacies reached the implementation phase and 35.6% remained in the testing phase at 12 months. A reach of 89.3% (n=844) was achieved. Fidelity average score was 8.45 (min: 6.2, max: 9.3) out of 10. The integration mean score was 3.39 (SD: 0.72) out of 5. MRF service outcomes were similar to the cluster RCT study; however, the magnitude of the outcomes was delayed. Conclusions The implementation of pharmacy services is a complex multifactorial process, conditioned by numerous implementation factors. In the absence of remuneration, the implementation of the MRF service is a slow process, taking at least 12 months to complete. Trial registration number CGFTRA-2017-01.es_ES
dc.language.isoenges_ES
dc.publisher10.1136/bmjopen-2019-036669es_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleVaras-Doval, R., Gastelurrutia, M. A., Benrimoj, S. I., Zarzuelo, M. J., Garcia-Cardenas, V., Perez-Escamilla, B., & Martínez-Martínez, F. (2020). Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice. BMJ open, 10(9), e036669. [doi:10.1136/bmjopen-2019-036669]es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1136/ bmjopen-2019-036669
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España